Die Tabelle gibt einen Überblick über alle offengelegten Patentanmeldungen, die der FVB für FMP-Technologien eingereicht hat:

Title Publication number Applicant* Status
Bifunctional peptide with mucoadhesive and virus binding properties WO2023187142 FUB, FVB Published
Novel FLT3 antibodies and antibody-drug-conjugates based thereon, therapeutic methods and uses thereof in combination with tyrosine kinase inhibitors WO2023105087 Tubulis, LMU, FVB, HZM Published
Conjugates comprising a Phosphorus (V) and a drug moiety WO2023083900 Tubulis, FVB Licensed
Thiol-Conjugation with Unsaturated Phosphorus (V) Compounds WO2022223783 FVB Licensed
MACC1-inhibitor for targeted therapy of MACC1-induced metastasis WO2022223664 MDC, Charité, FVB Published
Cellular uptake of Large Biomolecules enabled by Cell-surface-reactive cell-penetrating peptide additives WO2022180242 FVB Published
Improved CD30 targeting antibody drug conjugates and uses thereof WO2022136555 Tubulis, FVB, LMU Licensed
Inhibitors of NO production WO2022043465 MDC, FVB, Charité Published
1,2,4-triazole derivatives as tankyrase inhibitors WO2019243822 Oslo Univ Hospital, FVB, Univ Oulo Published
Heterocyclic compounds as class II phosphoinositide 3-kinase inhibitors WO2019234237 FVB Published
Polyproline mimetics of proline-derived module-15 WO2019162524 FVB, Univ zu Köln Licensed
Chemoselective thiol-conjugation with alkene or alkyne-phosphonothiolates and -phosphonates WO2019170710 FVB, LMU Licensed
Selective inhibitors of genotoxic stress-induced IKK/NF-kB pathways WO2018087389 MDC, FVB Published
Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates WO2018041985 FVB, LMU Licensed
Unusual substrates of tubulin tyrosine ligase WO2017186855 FVB, LMU Licensed
Antagonists of the thyroid-stimulating hormone receptor (TSHR) WO2017186793 FVB Licensed
Means and methods for site-specific functionalization of polypeptides WO2016066749 LMU, FVB Licensed
Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the same WO2016135199, WO2018019917 FVB, MDC Licensed
Inhibitors for inhibiting tumor metastasis WO2016092069 FVB, Univ zu Köln Licensed
Structural mimetics of proline-rich peptides and use thereof WO2013030111 FVB, Univ zu Köln Licensed
Induction of alpha helix conformations in proteins and peptides WO2011003626 Univ zu Köln, FVB Licensed
Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists WO2010047674 US Health, FVB Licensed
Structural mimetics of proline-rich peptides and the pharmaceutical use thereof WO2008040332 FVB Licensed
*Charité - Charité Universitätsmedizin Berlin; FUB - Freie Universität Berlin; FVB - Forschungsverbund Berlin e.V. (for its Leibniz-Forschungsinstitut für Molekulare Pharmakologie); HZM - Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundhei